Home
>
National Drug Code (NDC)
>
XGEVA
XGEVA - 55513-730-01 - (denosumab)
Drug Information of XGEVA
| Product NDC: | 55513-730 |
| Proprietary Name: | XGEVA |
| Non Proprietary Name: | denosumab |
| Active Ingredient(s): | 120 mg/1.7mL & nbsp; denosumab |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of XGEVA
| Product NDC: | 55513-730 |
| Labeler Name: | Amgen Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA125320 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20101118 |
Package Information of XGEVA
| Package NDC: | 55513-730-01 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (55513-730-01) > 1.7 mL in 1 VIAL, SINGLE-USE |
NDC Information of XGEVA
| NDC Code | 55513-730-01 |
| Proprietary Name | XGEVA |
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (55513-730-01) > 1.7 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 55513-730 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | denosumab |
| Dosage Form Name | INJECTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20101118 |
| Marketing Category Name | BLA |
| Labeler Name | Amgen Inc |
| Substance Name | DENOSUMAB |
| Strength Number | 120 |
| Strength Unit | mg/1.7mL |
| Pharmaceutical Classes |
